Cargando…
Molecular Advances in MAFLD—A Link between Sphingolipids and Extracellular Matrix in Development and Progression to Fibrosis
Metabolic-Associated Fatty Liver Disease (MAFLD) is a major cause of liver diseases globally and its prevalence is expected to grow in the coming decades. The main cause of MAFLD development is changed in the composition of the extracellular matrix (ECM). Increased production of matrix molecules and...
Autores principales: | Kołakowski, Adrian, Dziemitko, Sylwia, Chmielecka, Aleksandra, Żywno, Hubert, Bzdęga, Wiktor, Charytoniuk, Tomasz, Chabowski, Adrian, Konstantynowicz-Nowicka, Karolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569877/ https://www.ncbi.nlm.nih.gov/pubmed/36232681 http://dx.doi.org/10.3390/ijms231911380 |
Ejemplares similares
-
The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
por: Charytoniuk, Tomasz, et al.
Publicado: (2022) -
Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?
por: Charytoniuk, Tomasz, et al.
Publicado: (2020) -
Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
por: Berk, Klaudia, et al.
Publicado: (2021) -
The Influence of Coumestrol on Sphingolipid Signaling Pathway and Insulin Resistance Development in Primary Rat Hepatocytes
por: Zywno, Hubert, et al.
Publicado: (2021) -
Vitamin K2 as a New Modulator of the Ceramide De Novo Synthesis Pathway
por: Kołakowski, Adrian, et al.
Publicado: (2021)